Arbutus Biopharma stock price
아버터스 바이오파머NASDAQ:ABUS · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →Arbutus Biopharma last closed at $4.45 (-2.41%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is 5.7×. Its overall grade ranks 294 of 739 stocks in Healthcare.
About this company
Arbutus Biopharma last closed at $4.45 (-2.41%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 294/739
Valuation grade B+
Related stocks
- Gilead SciencesCustomer
HBV 치료제 공동개발·라이선스 계약의 핵심 파트너
- RocheCompetitor
B형간염 등 감염질환 치료제 개발에서 글로벌 제약 경쟁사
- ModernaCompetitor
RNA 기반 치료제·백신 플랫폼 분야의 경쟁사
ETFs holding this stock
First Trust Dow Jones Select MicroCap Index Fund
Details →About Arbutus Biopharma
- What technical signals does Arbutus Biopharma (ABUS) have?
- Arbutus Biopharma current technical signals: no active technical signal.
- Is Arbutus Biopharma a cup-and-handle pattern?
- No. Arbutus Biopharma has no valid Cup signal right now.
- What published figures are available for Arbutus Biopharma?
- Market cap: $855.84M. Trailing 12 months PER: 5.7×. Latest quarter PBR: 3.40×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Arbutus Biopharma, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).